124 related articles for article (PubMed ID: 19413038)
1. Colacicco v Apotex Inc. and the federal preemption of state tort remedies for health injuries: implications for public health policy and practice.
Burke T
Public Health Rep; 2009; 124(1):160-3. PubMed ID: 19413038
[No Abstract] [Full Text] [Related]
2. Bad medicine: prescription drugs, preemption, and the potential for a no-fault fix.
Smirniotopoulos A
Rev Law Soc Change; 2012; 35(4):793-862. PubMed ID: 22363960
[TBL] [Abstract][Full Text] [Related]
3. Not taking, just borrowing: government use of patented drugs.
Ossorio PN
Am J Bioeth; 2002; 2(3):51-2. PubMed ID: 12230861
[No Abstract] [Full Text] [Related]
4. Patents: the public interest versus the private privilege.
Parsi KP; Egan EA
Am J Bioeth; 2002; 2(3):45-6. PubMed ID: 12230857
[No Abstract] [Full Text] [Related]
5. An economic assessment of damage caps in medical malpractice litigation imposed by state laws and the implications for federal policy and law.
Frech HE; Hamm WG; Wazzan CP
Health Matrix Clevel; 2006; 16(2):693-722. PubMed ID: 16948253
[No Abstract] [Full Text] [Related]
6. Punishing health care fraud--is the GSK settlement sufficient?
Outterson K
N Engl J Med; 2012 Sep; 367(12):1082-5. PubMed ID: 22970920
[No Abstract] [Full Text] [Related]
7. Life, death, and monopoly rights in a democratic society.
Smith SJ
Am J Bioeth; 2002; 2(3):43-4. PubMed ID: 12230856
[No Abstract] [Full Text] [Related]
8. Bioterrorism and patent rights: "compulsory licensure" and the case of Cipro.
Resnik DB; DeVille KA
Am J Bioeth; 2002; 2(3):29-39. PubMed ID: 12230852
[No Abstract] [Full Text] [Related]
9. Equity First: Conceptualizing a Normative Framework to Assess the Role of Preemption in Public Health.
Carr D; Adler S; Winig BD; Montez JK
Milbank Q; 2020 Mar; 98(1):131-149. PubMed ID: 31951048
[TBL] [Abstract][Full Text] [Related]
10. Revisiting Factor VIII cases: is it time for an agency adjudication system?
Su YC
Food Drug Law J; 2008; 63(4):943-61. PubMed ID: 19601390
[No Abstract] [Full Text] [Related]
11. Jacobson v. Massachusetts: impact on informed consent and vaccine policy.
Severyn KM
J Pharm Law; 1996; 5(2):249-74. PubMed ID: 11660443
[No Abstract] [Full Text] [Related]
12. Renovations Needed: the FDA's Floor/Ceiling Framework, Preemption, and the Opioid Epidemic.
Abrams MR
Mich Law Rev; 2018 Oct; 117(1):143-71. PubMed ID: 30300989
[TBL] [Abstract][Full Text] [Related]
13. Vaccines and the law.
Sanzo M
Pepperdine Law Rev; 1991 Dec; 19(1):29-48. PubMed ID: 11659523
[No Abstract] [Full Text] [Related]
14. Good law from tragic facts--Congress, the FDA, and preemption.
Annas GJ
N Engl J Med; 2009 Sep; 361(12):1206-11. PubMed ID: 19759383
[No Abstract] [Full Text] [Related]
15. Compensation for research injuries. Part I.
Ladimer I
Med Moral Newsl; 1981 Feb; 18(2):5-8. PubMed ID: 11662810
[No Abstract] [Full Text] [Related]
16. Reagan signs bill on drug exports and payment for vaccine injuries.
Pear R
N Y Times Web; 1986 Nov; ():1, 9. PubMed ID: 11647821
[No Abstract] [Full Text] [Related]
17. Tort law and mass immunization programs: lessons from the polio and flu episodes.
Franklin MA; Mais JE
Calif Law Rev; 1977 Jul; 65(4):754-75. PubMed ID: 11664836
[No Abstract] [Full Text] [Related]
18. Single-State Tort Reform Analysis: Perspectives From the Volunteer State (Tennessee).
Angel W; Mays MA; Graves H; Radtke I
J Am Coll Radiol; 2018 Jun; 15(6):850-853. PubMed ID: 29729981
[No Abstract] [Full Text] [Related]
19. Vaccine-related injuries: alternatives to the tort compensation system.
Sturges SA
St Louis Univ Law J; 1986; 30(3):919-48. PubMed ID: 11649882
[No Abstract] [Full Text] [Related]
20. Compensation for and prevention of occupational disease.
American Public Health Association
Am J Public Health; 1984 Mar; 74(3):292-5. PubMed ID: 11644114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
